The Firm is engaged in the design, development, marketing and sale of business communication solutions. The firm attains price to earnings ratio of 33.58 and its current ratio stands at 0.90.
Gradient Investments Llc increased its stake in Colgate Palmolive Co (CL) by 5.39% based on its latest 2017Q2 regulatory filing with the SEC.
Colgate-Palmolive Company (NYSE:CL) operates in the Personal Products segment of the Consumer Goods sector. Concannon Wealth Management LLC now owns 1,605 shares of the company’s stock worth $119,000 after buying an additional 405 shares during the last quarter. Colgate Palmolive Co Com now has $64.08 billion valuation. The fund owned 43,552 shares of the company’s stock after buying an additional 2,278 shares during the period. About 216,237 shares traded.
At the moment, the top institutional investor at Colgate-Palmolive Company (NYSE:CL) is Vanguard Group Inc, which now holds 67,875,384 shares. It has underperformed by 10.47% the S&P500.
Since May 30, 2017, it had 0 insider buys, and 6 selling transactions for $8.63 million activity.
At Colgate-Palmolive Company, the percentage of institutional ownership is now at 74.79% percent of its total shares outstanding, with the total value of institutional ownership at $46.1 billion. Krilogy Financial LLC now owns 1,504 shares of the company’s stock worth $110,000 after buying an additional 46 shares during the last quarter. SULLIVAN GODFREY had sold 128,750 shares worth $7.41 million on Monday, June 12. The stock is now moving above its 20-Day Simple Moving Average of 1.34% with a 50-Day Simple Moving Average of 1.41 percent.
Boston Common Asset Management Llc decreased Check Point Software Tech Ltd (NASDAQ:CHKP) stake by 11,145 shares to 338,653 valued at $36.94 million in 2017Q2. It also upped Vanguard Intl Eqty Idx Allwrld (VEU) stake by 93,181 shares and now owns 124,825 shares. Illinois Tool Wks Inc Com (NYSE:ITW) was reduced too. Therefore 82% are positive.
Analysts on average have given a price target of $76.16 to Colgate-Palmolive Co. The firm has “Hold” rating given on Friday, July 21 by Jefferies. BNP Paribas upgraded Colgate-Palmolive Company (NYSE:CL) on Monday, January 18 to “Outperform” rating. Winslow Evans Crocker holds 0% in Colgate-Palmolive Company (NYSE:CL) or 32,645 shares. As per Thursday, November 2, the company rating was maintained by Citigroup. RBC Capital Markets maintained the stock with “Hold” rating in Friday, October 6 report. The company was maintained on Thursday, July 6 by Jefferies.
In other Colgate-Palmolive news, SVP John J. Huston sold 14,000 shares of the stock in a transaction dated Thursday, August 10th. The stock has “Hold” rating by Stifel Nicolaus on Monday, September 18.
Investors sentiment increased to 0.9 in Q2 2017. Its up 0.04, from 0.64 in 2017Q1. It improved, as 47 investors sold CL shares while 453 reduced holdings. That activity is comparable to their recent volume average trend of almost 1.46 million shares which they recorded over a period of three months. Amer Beacon Advsr holds 1,399 shares or 1.32% of its portfolio. Nomura Asset Mgmt Communications accumulated 23,700 shares. Andra Ap holds 0.01% of its portfolio in Splunk Inc (NASDAQ:SPLK) for 4,200 shares. Clinton Group Inc Inc invested 0.04% in Colgate-Palmolive Company (NYSE:CL). (NASDAQ:AAPL). Assetmark invested in 0.25% or 135,533 shares. Mai Capital Management has invested 0.09% in Colgate-Palmolive Company (NYSE:CL). Mercer Capital Advisers Incorporated reported 7,636 shares stake. Zacks downgraded the shares of CL in report on Wednesday, August 5 to “Hold” rating. Colgate-Palmolive comprises about 3.8% of Independence Trust CO’s portfolio, making the stock its 9th largest holding. Moreover, Clearline Capital Lp has 1.79% invested in the company for 490,365 shares. As for the shares, it has gone above the 20 days moving average and is now hovering within a distance of 1.34%. Personal Capital Advisors Corp now owns 394,028 shares of the company’s stock valued at $29,209,000 after acquiring an additional 21,456 shares during the period.
Ratings analysis reveals 100% of Recro Pharma’s analysts are positive. On Tuesday, October 3 the stock rating was maintained by SunTrust with “Buy”.
Moving average convergence divergence (MACD) shows that the stock is on a PRICE RELATIVITY trend. The rating was initiated by Atlantic Securities with “Overweight” on Wednesday, January 6. The stock of ILG Inc (NASDAQ:ILG) earned “Buy” rating by Oppenheimer on Tuesday, June 20. CL’s SI was 6.25M shares in November as released by FINRA. Gradient Investments Llc bought 4,874 shares as the company’s stock rose 3.95% with the market. Deerfield Management Co owns 1.90 million shares or 0.71% of their United States portfolio. The regular trading on 08-Nov-17 started at $73.15 but as the session moved on, the stock escalated, closing with a gain of 3.34%. Nikko Asset Mngmt Americas accumulated 142,100 shares.
About shares traded. Alliance California Municipal Income Fun (AKP) has declined 7.93% since November 8, 2016 and is downtrending. ILG Inc (ILG) has risen 97.56% since November 8, 2016 and is uptrending. It has outperformed by 13.83% the S&P500. Splunk Inc had 122 analyst reports since August 24, 2015 according to SRatingsIntel. During the same quarter in the previous year, the company earned $0.80 EPS. After $-0.48 actual earnings per share reported by Recro Pharma Inc for the previous quarter, Wall Street now forecasts 56.25% negative EPS growth.